Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma

被引:63
|
作者
Young, Jonathan R. [1 ]
Coy, Heidi [1 ]
Kim, Hyun J. [1 ]
Douek, Michael [1 ]
Lo, Pechin [1 ]
Pantuck, Allan J. [2 ]
Raman, Steven S. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, 757 Westwood Plaza,Ste 1638, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
关键词
MRI; multiphasic; oncocytoma; renal cell carcinoma; PATHOLOGICAL FINDINGS; HISTOLOGIC SUBTYPES; HELICAL CT; TUMORS; CLASSIFICATION; NEOPLASMS; PARAMETERS; FEATURES; DISEASE; SYSTEM;
D O I
10.2214/AJR.16.17152
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to investigate the performance of relative enhancement on multiphasic MRI to differentiate clear cell renal cell carcinoma (RCC) from other RCC subtypes (papillary and chromophobe) and oncocytoma. MATERIALS AND METHODS. For this study, we derived a cohort of 34 clear cell RCCs, nine oncocytomas, 12 papillary RCCs, and 10 chromophobe RCCs with a preoperative multiphasic dynamic contrast-enhanced MRI study with up to four phases (i.e., unenhanced, corticomedullary, nephrographic, excretory) from 2005 to 2016. These groups were evaluated for multiphasic enhancement and were compared using Kruskal-Wallis and Mann-Whitney tests. ROC curves were constructed and logistic regression analyses were performed to evaluate the performance of multiphasic enhancement in differentiating clear cell RCCs from the other three groups. RESULTS. Clear cell RCCs exhibited significantly greater relative signal intensity compared with uninvolved renal cortex in the corticomedullary phase (mean, 2.9) than oncocytomas (-21.7, p = 0.001), papillary RCCs (-53.0, p < 0.001), and chromophobe RCCs (-21.0, p < 0.001). Relative signal intensity in the corticomedullary phase differentiated clear cell RCCs from oncocytomas with an AUC of 0.90 and with an accuracy of 84% (32/38), sensitivity of 90% (27/30), and specificity of 63% (5/8) after controlling for lesion size, patient age, and patient sex. Relative corticomedullary signal intensity differentiated clear cell RCCs from oncocytomas and other RCC subtypes with an AUC of 0.93 and with an accuracy of 90% (53/59), sensitivity of 90% (27/30), and specificity of 90% (26/29) after controlling for lesion size, patient age, and patient sex. CONCLUSION. Multiphasic MRI enhancement may assist in differentiating clear cell RCC from oncocytomas and other RCC subtypes, if validated in prospective studies.
引用
收藏
页码:812 / 819
页数:8
相关论文
共 50 条
  • [1] Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC
    Waldert, Matthias
    Haitel, Andrea
    Marberger, Michael
    Katzenbeisser, Daniela
    Ozsoy, Mehmet
    Stadler, Elisabeth
    Remzi, Mesut
    BJU INTERNATIONAL, 2008, 102 (10) : 1381 - 1384
  • [2] Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT
    Young, Jonathan R.
    Coy, Heidi
    Douek, Michael
    Lo, Pechin
    Sayre, James
    Pantuck, Allan J.
    Raman, Steven S.
    ABDOMINAL RADIOLOGY, 2017, 42 (07) : 1911 - 1918
  • [3] Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT
    Jonathan R. Young
    Heidi Coy
    Michael Douek
    Pechin Lo
    James Sayre
    Allan J. Pantuck
    Steven S. Raman
    Abdominal Radiology, 2017, 42 : 1911 - 1918
  • [4] KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma
    Wang, HY
    Mills, SE
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (05) : 640 - 646
  • [5] Clear Cell Renal Cell Carcinoma: Discrimination from Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CT
    Young, Jonathan R.
    Margolis, Daniel
    Sauk, Steven
    Pantuck, Allan J.
    Sayre, James
    Raman, Steven S.
    RADIOLOGY, 2013, 267 (02) : 444 - 453
  • [6] Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): can novel molecular biomarkers help solve an old problem?
    Ng, Keng Lim
    Rajandram, Retnagowri
    Morais, Christudas
    Yap, Ning Yi
    Samaratunga, Hema
    Gobe, Glenda C.
    Wood, Simon T.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (02) : 97 - 104
  • [7] Clear Cell Papillary Cystadenoma of the Epididymis and Mesosalpinx: Immunohistochemical Relationship to Clear Cell Papillary Renal Cell Carcinoma (RCC)
    Cox, R.
    Epstein, J. I.
    MODERN PATHOLOGY, 2012, 25 : 199A - 199A
  • [8] Clear Cell Papillary Cystadenoma of the Epididymis and Mesosalpinx: Immunohistochemical Relationship to Clear Cell Papillary Renal Cell Carcinoma (RCC)
    Cox, R.
    Epstein, J. I.
    LABORATORY INVESTIGATION, 2012, 92 : 199A - 199A
  • [9] Tumor size is only an independend risk factor for clear cell renal cell carcinoma (RCC), but not for papillary RCC.
    Remzi, Mesut
    Klingler, Hans-Christoph
    Katzenbeisser, Daniela
    Waldert, Matthias
    Susani, Martin
    Tanovic, Enis
    Marberger, Michael
    JOURNAL OF ENDOUROLOGY, 2006, 20 : A42 - A42
  • [10] Differentiation of Renal Oncocytoma and Renal Clear Cell Carcinoma Using Relative CT Enhancement Ratio
    Ren, An
    Cai, Feng
    Shang, Yan-Ning
    Ma, En-Sen
    Huang, Zhen-Guo
    Wang, Wu
    Lu, Yan
    Zhang, Xue-Zhe
    CHINESE MEDICAL JOURNAL, 2015, 128 (02) : 175 - 179